Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.
Public ClinicalTrials.gov record NCT01197521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
(OSKIRA-1): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the effectiveness of two dosing regimens of fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking methotrexate but not responding. The study will last for 1 year.
Study identification
- NCT ID
- NCT01197521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 923 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Apr 7, 2014
2010 – 2012
United States locations
- U.S. sites
- 41
- U.S. states
- 24
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | — | — |
| Research Site | Huntsville | Alabama | — | — |
| Research Site | Tuscaloosa | Alabama | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Huntington Beach | California | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Santa Maria | California | — | — |
| Research Site | Santa Monica | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Bridgeport | Connecticut | — | — |
| Research Site | Lewes | Delaware | — | — |
| Research Site | Daytona Beach | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Marietta | Georgia | — | — |
| Research Site | Idaho Falls | Idaho | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Bowling Green | Kentucky | — | — |
| Research Site | Flowood | Mississippi | — | — |
| Research Site | Florissant | Missouri | — | — |
| Research Site | Richmond Heights | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Kalispell | Montana | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Olean | New York | — | — |
| Research Site | Asheville | North Carolina | — | — |
| Research Site | Greensboro | North Carolina | — | — |
| Research Site | Perrysburg | Ohio | — | — |
| Research Site | Lake Oswego | Oregon | — | — |
| Research Site | Erie | Pennsylvania | — | — |
| Research Site | Waxford | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Hixson | Tennessee | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Mesquite | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01197521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2014 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01197521 live on ClinicalTrials.gov.